Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 4,792 | 4,123 | 2,423 | 1,343 | 36 |
| Cost of Goods | 2,213 | 2,134 | 1,912 | 319 | 12 |
| Gross Profit | 2,579 | 1,989 | 511 | 1,024 | 24 |
| Operating Expenses | 12,095 | 9,016 | 6,136 | 4,834 | 4,473 |
| Operating Income | -9,304 | -6,893 | -4,713 | -3,491 | -4,437 |
| Other Income | -498 | -2,815 | -423 | -565 | -1,045 |
| Pre-tax Income | -9,802 | -9,707 | -5,136 | -4,055 | -5,482 |
| Income Tax | -325 | -386 | -458 | -392 | N/A |
| Net Income Continuous | -9,477 | -9,322 | -4,678 | -3,664 | -5,482 |
| Net Income | $-9,477 | $-9,322 | $-4,678 | $-3,664 | $-5,482 |
| EPS Basic Total Ops | -0.38 | -1.29 | -0.75 | -0.75 | -1.25 |
| EPS Basic Continuous Ops | -0.38 | -0.65 | -0.50 | -0.46 | -0.86 |
| EPS Diluted Total Ops | -0.38 | -1.29 | -0.75 | -0.75 | -1.25 |
| EPS Diluted Continuous Ops | -0.38 | -0.65 | -0.50 | -0.46 | -0.86 |
| EBITDA(a) | $-9,191 | $-6,629 | $-4,338 | $-2,965 | $-3,452 |